Home › NDC Lookup › RxCUI directory › RxCUI 2107520

Insulin degludec 100 UNT/ML Injectable Solution — RxCUI 2107520

RxNorm drug concept · Semantic clinical drug
RxCUI 2107520 Semantic clinical drug · SCD ● Current RxNorm concept 6 FDA products 9 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2107520
Official nameInsulin degludec 100 UNT/ML Injectable Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped6
Package NDCs mapped9
Reported Medicaid activity (SDUD)246,402 prescriptions · 51 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Insulin Degludec (rDNA Origin) Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Insulin degludec is a long-acting insulin used to help control blood sugar in people with type 1 or type 2 diabetes — including children as young as 1 year old. It gives your body...
  • What is insulin degludec (Tresiba) actually used for?
  • If you're an adult, you have flexibility — you can take it at any time of day that works for you, as long as at least 8 hours pass between doses if you ever need to adjust the timi...
  • When should I take it, and does it matter if I take it at different times each day?
📖 Read our full Insulin Degludec (rDNA Origin) Injection guide →

🕸️ Concept Web — How Insulin degludec 100 UNT/ML Injectable Solution Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Insulin degludec 100 UNT/ML Injectable Solution RxCUI 2107520

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Insulin degludec 1670007
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Tresiba 1670012
  3. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Insulin degludec Injectable Solution 2107519
    • Insulin degludec Injectable Product 1670009
    • Insulin degludec Injectable Solution [Tresiba] 2107521
    • Tresiba Injectable Product 1670015
    • Injectable Solution 316949
    • Injectable Product 1151126
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Insulin degludec 100 UNT/ML SCDC · 1670008
  • Insulin degludec Injectable Solution SCDF · 2107519
  • Insulin degludec Injectable Product SCDG · 1670009

Brand-Name Concepts

📦 FDA Products & Package NDCs

6 products · 9 package NDCs
9 package NDCs map to RxCUI 2107520 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00169-2550-13 3 SYRINGE, PLASTIC in 1 CARTON (0169-2550-13) / 3 mL in 1 S... Tresiba Novo Nordisk 2015-09-25
00169-2550-97 1 SYRINGE, PLASTIC in 1 CARTON (0169-2550-97) / 3 mL in 1 S... Tresiba Novo Nordisk 2015-09-25
00169-2660-15 5 SYRINGE, PLASTIC in 1 CARTON (0169-2660-15) / 3 mL in 1 S... Tresiba Novo Nordisk 2015-09-25
00169-2660-97 1 SYRINGE, PLASTIC in 1 CARTON (0169-2660-97) / 3 mL in 1 S... Tresiba Novo Nordisk 2015-09-25
00169-2662-11 1 VIAL, GLASS in 1 CARTON (0169-2662-11) / 10 mL in 1 VIAL,... Tresiba Novo Nordisk 2019-02-05
00169-2662-90 1 VIAL, GLASS in 1 CARTON (0169-2662-90) / 10 mL in 1 VIAL,... Tresiba Novo Nordisk 2019-02-05
73070-0400-11 1 VIAL, GLASS in 1 CARTON (73070-400-11) / 10 mL in 1 VIAL,... Insulin Degludec Novo Nordisk Pharma, Inc. 2022-07-01
73070-0403-15 5 SYRINGE, PLASTIC in 1 CARTON (73070-403-15) / 3 mL in 1 S... Insulin Degludec Novo Nordisk Pharma, Inc. 2022-07-01
73070-0503-15 3 SYRINGE, PLASTIC in 1 CARTON (73070-503-15) / 3 mL in 1 S... Insulin Degludec Novo Nordisk Pharma, Inc. 2022-07-01
Observed labelers: Novo Nordisk (6) · Novo Nordisk Pharma, Inc. (3) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.